RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
Toxic myopathy
View Complete Description-
Agents and mechanisms of toxic myopathy.
Authors: Ralph W Kuncl
Current opinion in neurology 2009 Oct -
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.
Authors: Risto Kerkelä, Luanda Grazette, Rinat Yacobi, Cezar Iliescu, Richard Patten, Cara Beahm, Brian Walters, Sergei Shevtsov, Stéphanie Pesant, Fred J Clubb,…
Nature medicine 2006 Aug
Thought leaders and organizations working on research involving toxic myopathy.
- National Institute of Allergy and Infectious Diseases (NIAID)
- PharmaMar
- Universidad Autonoma de San Luis Potosí
- U.S. Army Medical Research and Materiel Command
- National Cancer Institute (NCI)
- Brigham and Women's Hospital
- Johns Hopkins University School of Medicine
- University of Rochester
- Jefferson Medical College
- Long Island Jewish Medical Center
-
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
conditions: Myopathy
interventions: hematopoietic stem cell transplantation
-
Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer
conditions: Breast Cancer
interventions: Pegylated liposomal doxorubicin (Caelyx) ; Epirubicin
Community
-
No NextBio users were found for “toxic myopathy”.
Complete your user profile with your interests, if you want others to find you within the NextBio community.
-
No NextBio groups were found for “toxic myopathy”.
Be the first to start a group and share your interests with others within the NextBio community.
